Retrospective review of patients with lentigo maligna treated with topical imiquimod 5% (Aldara®) at a single tertiary UK centre: need for more practical standardised treatment guidelines in the UK.

Afzal, Usamah M; Ghadiri, Sina J; Sambi, Pavan; Muinonen-Martin, Andrew; Mitra, Angana

Afzal, Usamah M; Ghadiri, Sina J; Sambi, Pavan; Muinonen-Martin, Andrew; Mitra, Angana.

Affiliation

Afzal UM; Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Ghadiri SJ; Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Sambi P; Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Muinonen-Martin A; Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Mitra A; Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Clin Exp Dermatol ; 49(2): 163-165, 2024 Jan 25.

Article in En | MEDLINE | ID: mdl-37758510

Subject(s)

Antineoplastic Agents; Hutchinson's Melanotic Freckle; Skin Neoplasms; Humans; Imiquimod/therapeutic use; Hutchinson's Melanotic Freckle/drug therapy; Retrospective Studies; Antineoplastic Agents/therapeutic use; Aminoquinolines/adverse effects; Skin Neoplasms/drug therapy; Skin Neoplasms/chemically induced; United Kingdom; Administration, Topical

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Hutchinson's Melanotic Freckle / Antineoplastic Agents Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Clin Exp Dermatol Year: 2024 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google